Skip to main content
. 2020 Apr 9;2020:9182091. doi: 10.1155/2020/9182091

Figure 3.

Figure 3

Validation of differentially expressed plasma exosomal miRNAs by quantitative real-time PCR (qRT-PCR). (a) Relative expression of AC017053.1 in plasma exosomes from 24 CAD patients and 24 controls. (b) Relative expression of NONHSAT138339 in plasma exosomes from 24 CAD patients and 24 controls. (c) Relative expression of SOCS2-AS1 in plasma exosomes from 24 CAD patients and 24 controls. (d) Relative expression of SOCS2-AS1 in plasma exosomes from 84 CAD patients, 48 mCAS patients, and 41 controls. (e) Relative expression of SOCS2-AS1 in plasma exosomes from the stenosis group (merged 84 CAD patients and 48 mCAS patients) and 41 controls. ∗P < 0.05; & P < 0.01.